CLINICAL OUTCOME ASSESSMENT SCORES FOR PATIENTS WITH TRANSTHYRETIN AMYLOIDOSIS WITH OR WITHOUT ACCOMPANYING CARDIOMYOPATHY OR CONGESTIVE HEART FAILURE.

MLA

Kessler, Asia Sikora, et al. “Clinical Outcome Assessment Scores for Patients with Transthyretin Amyloidosis with or without Accompanying Cardiomyopathy or Congestive Heart Failure.” Journal of the American College of Cardiology (JACC), vol. 73, no. 9, Mar. 2019, p. 864. EBSCOhost, https://doi.org/10.1016/S0735-1097(19)31471-8.

APA

Kessler, A. S., Yarlas, A., Lovley, A., McCausland, K. L., Guthrie, S., Pollock, M., & White, M. K. (2019). Clinical Outcome Assessment Scores for Patients with Transthyretin Amyloidosis with or without Accompanying Cardiomyopathy or Congestive Heart Failure. Journal of the American College of Cardiology (JACC), 73(9), 864. https://doi.org/10.1016/S0735-1097(19)31471-8

Chicago

Kessler, Asia Sikora, Aaron Yarlas, Andrew Lovley, Kristen L. McCausland, Spencer Guthrie, Michael Pollock, and Michelle K. White. 2019. “Clinical Outcome Assessment Scores for Patients with Transthyretin Amyloidosis with or without Accompanying Cardiomyopathy or Congestive Heart Failure.” Journal of the American College of Cardiology (JACC) 73 (9): 864. doi:10.1016/S0735-1097(19)31471-8.